Reducing transfusion utilization for children with sickle cell anemia in sub‐Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial is a research paper published in American Journal of Hematology (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 091758
Wellcome Trust
Grant: 202800
Fogarty International Center
Grant: L40TW012438
Wellcome Trust
Grant: 202800/Z/16/Z
NHLBI NIH HHS
Grant: K23 HL153763
NICHD NIH HHS
Grant: T32 HD069054
NHLBI NIH HHS
Grant: U01 HL133883
American Society of Hematology
National Heart, Lung, and Blood Institute
Doris Duke Charitable Foundation
Doris Duke Charitable Foundation
FWCI
2.30
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals